Latest News

In recent months, major Gulf markets have experienced a subdued phase, largely influenced by softer global oil prices and oversupply concerns. Despite these challenges, dividend stocks in the Middle East continue to attract attention for their potential to provide steady income streams amidst fluctuating market conditions. Understanding what makes a good dividend stock is crucial in such an environment; factors like stable earnings, strong cash flow, and a history of consistent payouts can be...

Shareholders appeared unconcerned with Power and Water Utility Company for Jubail and Yanbu's ( TADAWUL:2083...

It is hard to get excited after looking at Umm Al Qura for Development and Construction's (TADAWUL:4325) recent...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...

Phathom Pharmaceuticals (PHAT) has started dosing the first patient in its Phase 2 clinical trial for VOQUEZNA, targeting eosinophilic esophagitis in adults. This marks a meaningful step in broadening the therapeutic reach of VOQUEZNA. See our latest analysis for Phathom Pharmaceuticals. That milestone comes in the wake of a few busy weeks for Phathom Pharmaceuticals, including conference presentations and improved revenue guidance for 2025. The 1-year total shareholder return of nearly 50%...

COSCO SHIPPING Ports Limited recently reported its third quarter and nine-month results for the period ended September 30, 2025, with sales rising to US$428.67 million and net income at US$82.5 million in the third quarter, both higher than the same period last year. A unique detail from the announcement is that while sales and net income grew, basic and diluted earnings per share for the third quarter declined slightly compared to a year ago, reflecting the impact of share issuance on...

On November 5, 2025, The Hongkong and Shanghai Hotels, Limited reported its unaudited third quarter operating results, revealing varied RevPAR figures across key regions, including HK$2,477 for Greater China and HK$9,234 for Europe. While Greater China and Other Asia saw year-over-year declines in RevPAR, Europe and the USA experienced solid gains, indicating shifting regional demand patterns for The Peninsula Hotels. We'll explore how diverging RevPAR trends, particularly the strong growth...

Karoon Energy (ASX:KAR) has just announced Ms Carri Lockhart as its new Chief Executive Officer and Managing Director. This marks a key leadership change that could influence the company’s next phase of strategy and performance. See our latest analysis for Karoon Energy. Karoon Energy’s latest executive shake-up comes as investors refocus on momentum in the share price. With a strong 1-day return of 4.43% and a 1-year total shareholder return of nearly 29%, recent gains suggest the market is...

Crédit Agricole has extended its lease for about 85,000 square feet at Swire Properties (SEHK:1972) Pacific Place until 2034. This move reaffirms a partnership that highlights ongoing faith in Hong Kong's office property sector. See our latest analysis for Swire Properties. The renewed partnership with Crédit Agricole arrives as Swire Properties’ share price shows robust momentum, jumping 4.1% in a single day and building on a year-to-date share price return of nearly 47%. The stock’s...

When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 28x, you may consider...

Capio Hjärnhälsan recently announced the opening of a new 1,100 square metre psychiatric clinic, occupying an entire floor at Drottninggatan 7 in central Helsingborg, under a five-year lease agreement with Wihlborgs Fastigheter. This move strengthens Wihlborgs Fastigheter’s healthcare property portfolio and underlines sustained tenant demand for modern clinical space in a central location. We’ll examine how the new healthcare lease with Capio Hjärnhälsan supports Wihlborgs Fastigheter’s...

On October 31, Nanobiotix announced it had entered a royalty-based financing agreement with HealthCare Royalty to secure up to US$71 million in non-dilutive capital, supporting its operations and the advancement of nanotherapeutic platforms. This agreement signals a reinforced financial position for Nanobiotix, potentially underpinning its ability to sustain research and development initiatives over the long term. We’ll explore how this infusion of non-dilutive capital from the royalty-based...

NetLink NBN Trust announced its half-year results on November 3, 2025, reporting revenue of S$207.11 million and net income of S$43.54 million, while declaring a distribution of 2.71 Singapore cents per unit to unitholders. The combination of higher sales but lower earnings provides important context for investors assessing the Trust’s cash flow and distribution policy. We’ll explore how NetLink NBN Trust’s commitment to distributing all available cash shapes its investment narrative amid...

As the Australian market experiences a cautious optimism amid ongoing global economic uncertainties, investors are keeping a close eye on potential opportunities. Penny stocks, often seen as relics of past speculative fervor, continue to offer intriguing possibilities for those willing to explore smaller or newer companies with strong financial health. With this in mind, we'll examine several penny stocks that could offer both value and growth potential in today's ever-evolving market landscape.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Most readers would already be aware that Lulu Retail Holdings' (ADX:LULU) stock increased significantly by 7.0% over...

The market shrugged off Space42 PLC's ( ADX:SPACE42 ) solid earnings report. We think that investors might be worried...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

enGene Holdings recently reported additional preliminary efficacy data from its pivotal Phase 2 LEGEND trial for detalimogene voraplasmid in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer, along with a protocol amendment changing the primary clinical endpoint after discussions with the FDA. This update reveals that earlier patients in the study experienced a lower 12-month complete response rate compared to FDA-approved therapies, leading to significant...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

DEUTZ (XTRA:DEZ) just published its financial results for the first three quarters of the year, sharing details that investors will be watching closely given the mix of higher sales but lower net income. See our latest analysis for DEUTZ. DEUTZ’s shares have seen some volatility lately, but the big picture is hard to miss. After a 93.8% jump in share price since January and a one-year total shareholder return of 105%, there is real momentum at play, even with recent earnings raising questions...

IAMGOLD (TSX:IMG) recently reported increased gold production and sales for both the third quarter and year to date. The company also announced the initiation of a buyback program covering up to 10% of outstanding shares. See our latest analysis for IAMGOLD. It has been a pivotal year for IAMGOLD, with momentum noticeably building following higher gold production and the announcement of a major buyback program. After a quiet start, excitement around operational gains has fueled a 152% share...

Key Insights KRAFTON's estimated fair value is ₩423,871 based on 2 Stage Free Cash Flow to Equity KRAFTON is estimated...